| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $63.1M | $59.7M | $54.2M |
| YoY Revenue Growth % | +5.7% | +10.0% | — |
| Gross Profit | $49.4M | $47.6M | — |
| Gross Margin % | 78.3% | 79.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$45.9M | -$40.3M | $1.1M |
| Operating Margin % | -72.8% | -67.5% | 2.1% |
| Net Income (GAAP) | -$41.2M | -$39.4M | -$316.0K |
| EBITDA (Normalized) | -$45.4M | -$39.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$33.9M | -$19.8M | $1.2M |
| Capital Expenditures (CapEx) | $618.0K | $505.0K | — |
| Free Cash Flow (FCF) | -$34.5M | -$20.3M | $1.2M |
| FCF Margin % | -54.7% | -34.0% | 2.2% |
| Return on Invested Capital (ROIC %) | -45.0% | -39.5% | — |
| Cash & Short-Term Equivalents | $9.0M | $19.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $75.0M | $100.1M | — |